Novartis Korea has gone through a period of transformation over the past few years. As part of the global headquarters' large-scale reorganization, the company's long-established oncology and pharmaceutical businesses were merged.

Although the businesses were operating under one name, Novartis, the two departments were operated independently. In fact, Marketing and Sales, as well as supporting departments such as Market Access, Government Affairs, and Licensing, were all organized separately. However, through the integration process, all of the departments were merged into one and led by a single head. As a result, a general manager of the integrated corporation was appointed for the first time since i